EUROLAB
ph-eur-2414-determination-of-inorganic-impurities
Impurity Profiling EMA Guideline on Genotoxic Impurities in PharmaceuticalsEMA Reflection Paper on Low Level ImpuritiesFDA Guidance: Microbial Impurities and Endotoxin LevelsFDA Guidance: Threshold of Toxicological Concern (TTC) for ImpuritiesFDA ICH M3(R2): Impurities in Safety StudiesFDA Q&A on Impurities in Generic Drug ApplicationsFDA Q&A: Managing Impurities in Complex APIsICH E14: QT Interval Evaluation and Impurity ImpactICH M7: Mutagenic Impurity Risk AssessmentICH Q10: Pharmaceutical Quality System for Impurity ManagementICH Q11: Impurity Control Strategy in Drug Substance DevelopmentICH Q12: Lifecycle Management of Impurity Control StrategyICH Q1E: Evaluation of Stability Data Related to Impurity FormationICH Q2(R1): Validation of Analytical Methods for Impurity TestingICH Q3A: Organic Impurity Profiling in Drug SubstancesICH Q3B: Impurity Testing in Finished Drug ProductsICH Q3C: Residual Solvent ProfilingICH Q3D: Elemental Impurity Risk AssessmentICH Q3F: Impurity Guidelines for Biotechnology ProductsICH Q4B: Harmonization of Analytical Procedures for Impurity TestingICH Q5C: Impurity Monitoring in Biotechnological ProductsICH Q6A: Specifications and Acceptance Criteria for ImpuritiesICH S3A: Impurities Arising from Degradation ProductsICH S6: Biotech Product Impurity ProfilingICH S7A: Safety Pharmacology Impurity EvaluationICH S9: Impurities in Oncology ProductsISO 10993-18: Chemical Characterization and Impurity AnalysisISO 17025: Accreditation for Impurity Testing LaboratoriesJP General Rule 2.60: Limit Test for ImpuritiesPh. Eur. 2.2.28: Gas Chromatography for Impurity DetectionPh. Eur. 2.2.38: Thin-Layer Chromatography for ImpuritiesPh. Eur. 2.2.46: Chromatographic Separation for Impurity AnalysisPh. Eur. 2.4.20: Limit Test for Heavy Metals in ImpuritiesPh. Eur. 2.4.24: Related Substances by HPLC in APIsPh. Eur. 2.4.29: Limit Test for Sulfated Ash ImpuritiesPh. Eur. 2.5.13: Oxidizing Impurity TestsPh. Eur. 2.9.40: Uniformity of Dosage Units and Related ImpuritiesPh. Eur. 5.10: Control of Impurities in Substances for Pharmaceutical UsePh. Eur. 5.4: Impurities in Radiopharmaceutical PreparationsUSP <1010>: Analytical Data Integrity in Impurity ReportingUSP <1031>: The Biocompatibility of Materials and ImpuritiesUSP <1051>: Cleaning Validation Limits and Residual ImpuritiesUSP <1058>: Analytical Instrument Qualification for Impurity StudiesUSP <1078>: Good Manufacturing Practices for Impurity ReductionUSP <1085>: Evaluation of Impurity Method PerformanceUSP <1086>: Impurities in Drug SubstancesUSP <1088>: Forced Degradation Studies for Impurity CharacterizationUSP <1091>: Impurity Isolation and Characterization TechniquesUSP <1099>: Acceptable Analytical Performance CriteriaUSP <1121>: Bulk Pharmaceutical Chemicals and Impurity HandlingUSP <1151>: Pharmaceutical Dosage Forms and Impurity ConsiderationUSP <1191>: Stability Testing of Compounded PreparationsUSP <1222>: Terminal Sterilization Impact on ImpuritiesUSP <1224>: Transfer of Impurity Test ProceduresUSP <1225>: Validation of Compendial Procedures for ImpuritiesUSP <1226>: Verification of Compendial Procedures for Impurity DetectionUSP <1231>: Water for Pharmaceutical Purposes and Impurity EffectsUSP <1232>: Water Activity and Impurity StabilityUSP <1241>: Capsules and Shell Impurity InteractionUSP <1251>: Weighing on Analytical Balances for Micro-ImpuritiesUSP <161>: Transdermal Delivery Systems and Impurity ControlUSP <197>: Spectrophotometric Identification of ImpuritiesUSP <233>: Elemental Impurities Profiling Using ICP-MSUSP <41>: Balances Used for Impurity Weight DeterminationUSP <466>: Identification and Quantification of DegradantsUSP <467>: Residual Solvent Testing in APIs and ExcipientsUSP <476>: Impurity Profiling for New Drug ApplicationsUSP <621>: Chromatography Conditions for Impurity IdentificationUSP <730>: Plasma Spectrochemistry for Impurity ProfilingUSP <791>: pH Determination Impact on Impurity SolubilityUSP <797>: Sterile Compounding and Impurity ControlUSP <800>: Hazardous Drug Handling Based on Impurity RiskUSP <851>: Spectrophotometry and Light Scattering for ImpuritiesUSP <853>: Atomic Absorption Spectroscopy for Trace ImpuritiesUSP <857>: UV-Vis Spectroscopy for Impurity QuantificationUSP <85>: Bacterial Endotoxin Limits Related to Impurity SafetyUSP <891>: Nuclear Magnetic Resonance (NMR) for Structural ElucidationUSP <905>: Content Uniformity Related to ImpuritiesUSP <905>: Uniformity of Dosage Units Affected by ImpuritiesUSP <941>: Characterization of Impurity Solubility and pKaWHO TRS 970 Annex 2: Impurity Control in Medicines

Comprehensive Guide to Eurolabs Laboratory Testing Service for Ph. Eur. 2.4.14: Determination of Inorganic Impurities

Ph. Eur. 2.4.14: Determination of Inorganic Impurities is a laboratory testing service provided by Eurolab, which adheres to the strict standards and regulations set forth by various international organizations. The primary standard governing this testing service is the European Pharmacopoeia (Ph. Eur.) monograph for the determination of inorganic impurities.

Relevant Standards:

  • Ph. Eur. 2.4.14: Determination of Inorganic Impurities
  • ISO 17025:2005 - General requirements for the competence of testing and calibration laboratories
  • ASTM E2500-11 - Practice for Addressing Electromagnetic Compatibility (EMC) in the Design, Development, and Testing of Naval Systems
  • EN ISO/IEC 17025:2018 - General requirements for the competence of testing and calibration laboratories
  • Standard Development Organizations:

    The European Pharmacopoeia Commission is responsible for developing and maintaining Ph. Eur. standards, including Ph. Eur. 2.4.14. The International Organization for Standardization (ISO) develops ISO standards, such as ISO 17025, which provides requirements for testing and calibration laboratories. Other organizations, like the American Society for Testing and Materials (ASTM), also develop standards relevant to this testing service.

    Standard Evolution and Updates:

    Standards evolve over time to reflect advances in technology, new scientific findings, or changes in regulatory requirements. When a standard is updated, laboratories must adapt their testing methods and procedures accordingly. Eurolab ensures that its testing services are up-to-date with the latest standards and regulations.

    International and National Standards:

    Ph. Eur. 2.4.14 applies globally, but national standards may also be relevant in specific regions. For example:

  • In the European Union (EU), Ph. Eur. 2.4.14 is applicable.
  • In the United States (US), the FDA regulates pharmaceuticals and requires compliance with USP <232> and <233>.
  • In Canada, Health Canada regulates pharmaceuticals and requires compliance with Ph. Eur. 2.4.14.
  • Standard Compliance Requirements:

    Industry-specific requirements for standard compliance vary depending on factors such as product type, intended use, and geographical region. Eurolabs testing services ensure that clients meet regulatory requirements for their specific industry and market.

    Standard-Related Case Studies:

  • Example 1: A pharmaceutical company required Ph. Eur. 2.4.14 testing to ensure compliance with EU regulations.
  • Example 2: A cosmetic manufacturer needed testing to comply with US FDA guidelines, specifically USP <232> and <233>.
  • Why This Test Is Needed:

    Ph. Eur. 2.4.14 is necessary for several reasons:

    1. Regulatory Compliance: Testing for inorganic impurities ensures that pharmaceutical products meet regulatory requirements.

    2. Product Safety: The presence of inorganic impurities can pose health risks to consumers, making testing crucial.

    3. Quality Assurance: Regular testing helps manufacturers maintain quality control and assurance.

    Ph. Eur. 2.4.14 testing involves several steps:

    1. Sample Preparation:

    Selecting representative samples

    Weighing and homogenizing samples

    Preparing samples for analysis

    2. Testing Equipment and Instruments:

    Inductively Coupled Plasma Mass Spectrometry (ICP-MS)

    Atomic Absorption Spectroscopy (AAS)

    Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES)

    3. Testing Environment Requirements:

    Temperature control

    Humidity control

    Pressure control

    Test Parameters and Conditions:

    1. Instrument Settings: ICP-MS or AAS parameters are set based on the specific elements to be analyzed.

    2. Sample Size and Statistical Considerations: Sample size is determined by the number of units required for analysis, while statistical considerations ensure that test results are representative.

    Measurement and Analysis Methods:

    1. ICP-MS: Measures elemental concentrations using mass spectrometry.

    2. AAS: Measures elemental concentrations using atomic absorption spectroscopy.

    3. Data Analysis: Software is used to analyze data and calculate concentration values.

    Calibration and Validation Procedures:

    1. Instrument Calibration: Regular calibration ensures accurate measurements.

    2. Method Validation: Studies are conducted to validate the accuracy, precision, and robustness of testing methods.

    Quality Control Measures During Testing:

    1. Blank Samples: Blank samples are analyzed to detect contamination or matrix effects.

    2. Reference Materials: Reference materials are used for method validation and calibration.

    3. Proficiency Testing: Eurolab participates in proficiency testing schemes to ensure accuracy and precision.

    Persuasive Case Studies:

  • Example 1: A pharmaceutical companys product passed regulatory requirements after Ph. Eur. 2.4.14 testing at Eurolab.
  • Example 2: A cosmetic manufacturer improved their quality control processes by incorporating regular Ph. Eur. 2.4.14 testing.
  • Conclusion:

    Ph. Eur. 2.4.14 is a critical laboratory testing service for ensuring regulatory compliance and product safety in the pharmaceutical industry. By adhering to strict standards and regulations, Eurolab provides accurate and reliable results that help manufacturers maintain quality control and assurance.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers